Nano-X Imaging Ltd (NASDAQ:NNOX) shares are trading higher by 48.6% to $14.06 during Friday’s session on upward momentum after NVIDIA Corp recently reported a 59,632 share stake in the company.
The stock is also gaining after the FDA recently approved NanoX’s HealthFLD, an AI software designed to analyze liver attenuation in CT scans of patients aged 18 to 75. This software aids in identifying fatty liver, which is an early indicator of metabolic dysfunction-related liver diseases.
How To Buy NNOX Stock
By now you're likely curious about how to participate in the market for Nano X Imaging – be it to ...
NNOX) Stock?>Full story available on Benzinga.com